The C5b-9 Membrane Attack Complex of Complement Activation Localizes to Villous Trophoblast Injury in Vivo and Modulates Human Trophoblast Function in Vitro

Overview

Journal Placenta

Publisher Elsevier

Specialties Gynecology & Obstetrics
Physiology
Reproductive Medicine

Date 2008 Sep 12

PMID 18783824

Citations 37

Authors

R Rampersad

A Barton

Y Sadovsky

D M Nelson

Affiliations

Soon will be listed here.

Abstract

The complement system plays an important role in normal human pregnancy. Uncontrolled activation of this system has been associated with many disease states. We tested the hypothesis that the C5b-9 membrane attack complex (MAC) localizes to sites of villous injury and modulates trophoblast function. Placental sections from pregnancies with no complications, intrauterine growth restriction, or preeclampsia were immunostained and the surface density for MAC and fibrin was determined by morphometric analysis. Primary cytotrophoblasts from term placentas were cultured in a FiO(2) of <1%, 8% and 20% with 10% human serum containing active MAC or heat-inactivated control serum. Immunofluorescent MAC binding to trophoblast was quantified, and the neoepitopes formed in cytokeratin 18 filaments and poly-ADP-ribose polymerase during apoptosis were used to measure cell death. Trophoblast differentiation was assessed by HCG secretion, formation of syncytia, and expression of syncytin. MAC localized to fibrin deposits in normal placentas, and especially in placentas from IUGR and preeclampsia. MAC binding to cytotrophoblasts was inversely proportional to FiO(2) and enhanced apoptosis. MAC increased markers of differentiation in cultures at 72h (medium HCG, syncytia and syncytin expression). Our findings demonstrate that MAC associates with fibrin deposits at sites of villous injury in vivo. Hypoxia also enhances MAC deposition in cultured trophoblasts and MAC alters trophoblast function in a phenotype specific manner.

Citing Articles

Circulating extracellular vesicles and neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsia.

Ramos A, Youssef L, Molina P, Torramade-Moix S, Martinez-Sanchez J, Moreno-Castano A Front Immunol. 2024; 15:1488127.

PMID: 39735539 PMC: 11671372. DOI: 10.3389/fimmu.2024.1488127.

Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study.

Venou T, Vetsiou E, Varelas C, Daniilidis A, Psarras K, Koravou E J Pers Med. 2024; 14(4).

PMID: 38673014 PMC: 11051193. DOI: 10.3390/jpm14040387.

Exposure to endocrine disrupting chemicals impacts immunological and metabolic status of women during pregnancy.

Merrill A, Sobolewski M, Susiarjo M Mol Cell Endocrinol. 2023; 577:112031.

PMID: 37506868 PMC: 10592265. DOI: 10.1016/j.mce.2023.112031.

The role of immune cells and mediators in preeclampsia.

Deer E, Herrock O, Campbell N, Cornelius D, Fitzgerald S, Amaral L Nat Rev Nephrol. 2023; 19(4):257-270.

PMID: 36635411 PMC: 10038936. DOI: 10.1038/s41581-022-00670-0.

The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia.

David M, Naicker T Obstet Gynecol Sci. 2023; 66(4):253-269.

PMID: 36597584 PMC: 10375220. DOI: 10.5468/ogs.22175.

References

Nelson D . Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta. 1996; 17(7):387-91. DOI: 10.1016/s0143-4004(96)90019-3. View

Levy R, Smith S, Chandler K, Sadovsky Y, Nelson D . Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol. 2000; 278(5):C982-8. DOI: 10.1152/ajpcell.2000.278.5.C982. View

Richani K, Romero R, Soto E, Espinoza J, Nien J, Chaiworapongsa T . Unexplained intrauterine fetal death is accompanied by activation of complement. J Perinat Med. 2005; 33(4):296-305. DOI: 10.1515/JPM.2005.052. View

Miller R, Genbacev O, Turner M, Aplin J, Caniggia I, Huppertz B . Human placental explants in culture: approaches and assessments. Placenta. 2005; 26(6):439-48. DOI: 10.1016/j.placenta.2004.10.002. View

. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2005; 99(1):159-67. DOI: 10.1016/s0029-7844(01)01747-1. View

Cybulsky A, Takano T, Papillon J, Khadir A, Liu J, Peng H . Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells. J Biol Chem. 2002; 277(44):41342-51. DOI: 10.1074/jbc.M204694200. View

Frank H, Malekzadeh F, Kertschanska S, Crescimanno C, Castellucci M, Lang I . Immunohistochemistry of two different types of placental fibrinoid. Acta Anat (Basel). 1994; 150(1):55-68. DOI: 10.1159/000147602. View

Hu C, Smith S, Pang L, Sadovsky Y, Nelson D . Enhanced basal apoptosis in cultured term human cytotrophoblasts is associated with a higher expression and physical interaction of p53 and Bak. Placenta. 2005; 27(9-10):978-83. DOI: 10.1016/j.placenta.2005.11.004. View

Tjoa M, Cindrova-Davies T, Spasic-Boskovic O, Bianchi D, Burton G . Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol. 2006; 169(2):400-4. PMC: 1698796. DOI: 10.2353/ajpath.2006.060161. View

10.

Rus H, Cudrici C, David S, Niculescu F . The complement system in central nervous system diseases. Autoimmunity. 2006; 39(5):395-402. DOI: 10.1080/08916930600739605. View

11.

Mayhew T . Stereology and the placenta: where's the point? -- a review. Placenta. 2006; 27 Suppl A:S17-25. DOI: 10.1016/j.placenta.2005.11.006. View

12.

Nelson D, Crouch E, Curran E, Farmer D . Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta. Am J Pathol. 1990; 136(4):855-65. PMC: 1877640. View

13.

Mayhew T, Ohadike C, Baker P, Crocker I, Mitchell C, Ong S . Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003; 24(2-3):219-26. DOI: 10.1053/plac.2002.0900. View

14.

Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, Zamudio S . Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005; 90(7):4299-308. PMC: 6428057. DOI: 10.1210/jc.2005-0078. View

15.

Shamonki J, Salmon J, Hyjek E, Baergen R . Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol. 2007; 196(2):167.e1-5. PMC: 2248299. DOI: 10.1016/j.ajog.2006.10.879. View

16.

Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z . Cell signals transduced by complement. Mol Immunol. 2004; 41(6-7):583-97. DOI: 10.1016/j.molimm.2004.04.007. View

17.

Haeger M, Unander M, Tylman M, Bengtsson A . Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 1992; 79(1):19-26. View

18.

Kim D, Song W . Membrane complement regulatory proteins. Clin Immunol. 2005; 118(2-3):127-36. DOI: 10.1016/j.clim.2005.10.014. View

19.

van de Geijn F, Roos A, de Man Y, Laman J, de Groot C, Daha M . Mannose-binding lectin levels during pregnancy: a longitudinal study. Hum Reprod. 2006; 22(2):362-71. DOI: 10.1093/humrep/del392. View

20.

Holers V, Girardi G, Mo L, Guthridge J, Molina H, Pierangeli S . Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med. 2002; 195(2):211-20. PMC: 2193604. DOI: 10.1084/jem.200116116. View